Dignitana AB Publishes Q2 2022 Interim Report
Strategic growth aligned with clear vision:
Strong growth continues at 30 percent
Financial highlights Q2 2022
- Net sales amounted to 18,3 MSEK (14,0), an increase of 30 percent over the same period in 2021.
- Operating result amounted to 0.1 MSEK (-9,4).
- Net result after financial items amounted to -0,2 MSEK (-9,7).
- Earnings per share were 0,00 SEK (-0,15).
- Cash Balance amounted to 7,3 MSEK (36,3).
- Average Daily Treatment Revenue (ADTR)* was 201 TSEK (163), an increase of 23 percent over the same period in 2021.
Significant events during the period
-
The Annual Report for 2021 was published 28 April 2022.
-
The Annual General Meeting was held on 19 May 2022.
-
Catarina Mård Löwenadler became Chief Executive Officer of Dignitana on 19 May 2022.
-
The company appointed Ulf Jönsson as Chief Financial Officer beginning 1 July 2022.
-
Dignitana AB secured a line of credit in the amount of SEK 10 million from the company’s largest shareholder, Agartha AB, to support the strategic growth of the company.
Business highlights during the period
- The American Medical Association reaffirmed their policy supporting scalp cooling and reimbursement for the treatment.
Key Figures
|
DIGNITANA GROUP |
Q2 2022 |
Q2 2021 |
Q1-Q2 2022 |
Q1-Q2 2021 |
Full Year 2021 |
| Net sales, TSEK | 18 284 | 14 038 | 34 148 | 27 203 | 57 073 |
| Total revenues, TSEK | 24 067 | 17 174 | 40 777 | 31 331 | 62 376 |
| Net profit after financial items, TSEK | -232 | -9 660 | -6 740 | -17 324 | -43 076 |
| Cash and bank balances, TSEK | 7 312 | 36 333 | 7 312 | 36 333 | 14 501 |
| Earnings per share before and after dilution, SEK | 0,00 | -0,15 | -0,10 | -0,28 | -0,66 |
| Average Daily Treatment Revenue*, TSEK | 201 | 163 | 190 | 146 | 147 |
* ADTR includes pay-per-treatment revenue from patients and facilities. Does not include lease revenue or disposable sales.
All financial reports are available at www.dignitana.com/investor-relations/financial-reports/
This disclosure contains information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 18-08-2022 08:00 CET.
